Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis

NCT06509243 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.

NCT NCT06509243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06509243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis
Lead sponsor
Medical University of Silesia
Phase
Not applicable
Overall status
Completed
Start date
February 10, 2023
Completion date
April 10, 2024
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis